Daijun Wang
Overview
Explore the profile of Daijun Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu J, Ren L, Wu T, Hua L, Wang D, Wang Y, et al.
J Neurooncol
. 2025 Feb;
PMID: 40019713
Purpose: Radio-resistance poses a significant challenge in meningioma treatment. This study aimed to establish radio-resistant meningioma cell lines and uncover molecular mechanisms driving radio-resistance to identify potential biomarkers and therapeutic...
2.
Ren L, Xie Q, Deng J, Chen J, Yu J, Wang D, et al.
J Neurosurg
. 2024 Mar;
141(3):593-601.
PMID: 38552238
Objective: Psammomatous meningiomas (PMs) are a rare histological subtype of meningioma but are rather frequent in spinal meningiomas. The authors aimed to analyze the incidence, clinical features, molecular alterations, long-term...
3.
Teng M, Li Z, Gu Y, Fan Y, Wang D, Liu M, et al.
Biochem Biophys Res Commun
. 2023 Dec;
694:149383.
PMID: 38150918
Metformin is currently a strong candidate antitumor agent for multiple cancers, and has the potential to inhibit cancer cell viability, growth, and proliferation. Metabolic reprogramming is a critical feature of...
4.
Ren L, Chen J, Deng J, Qing X, Cheng H, Wang D, et al.
J Neurooncol
. 2023 Dec;
166(1):59-71.
PMID: 38146046
Purpose: Atypical meningiomas could manifest early recurrence after surgery and even adjuvant radiotherapy. We aimed to construct a clinico-radiomics model to predict post-operative recurrence of atypical meningiomas based on clinicopathological...
5.
Cheng H, Hua L, Tang H, Bao Z, Xu X, Zhu H, et al.
J Mol Cell Biol
. 2023 Oct;
15(10).
PMID: 37791390
Meningioma is one of the most common primary neoplasms in the central nervous system, but no specific molecularly targeted therapy has been approved for the clinical treatment of aggressive meningiomas....
6.
Huo C, Gu Y, Wang D, Zhang X, Tang F, Zhao B, et al.
J Cancer Res Clin Oncol
. 2023 Aug;
149(17):15335-15348.
PMID: 37639009
Purpose: Tripartite motif-containing protein 21 (TRIM21) has E3 ubiquitin ligase activity and is involved in the regulation of various biological processes in vivo. TRIM21 has been found to have strong...
7.
Chen J, Hua L, Xu X, Jiapaer Z, Deng J, Wang D, et al.
World Neurosurg
. 2023 Jun;
176:e501-e514.
PMID: 37263494
Background: Dysregulation of immune infiltration critically contributes to the tumorigenesis and progression of meningiomas. However, the landscape of immune microenvironment and key genes correlated with immune cell infiltration remains unclear....
8.
Huo C, Zhang X, Gu Y, Wang D, Zhang S, Liu T, et al.
Biomolecules
. 2023 May;
13(5).
PMID: 37238742
Gastric organoids are biological models constructed in vitro using stem cell culture and 3D cell culture techniques, which are the latest research hotspots. The proliferation of stem cells in vitro...
9.
Ren L, Hua L, Deng J, Cheng H, Wang D, Chen J, et al.
Neurosurgery
. 2022 Dec;
92(4):745-755.
PMID: 36512828
Background: WHO grade 2 meningiomas, including atypical, chordoid, and clear cell subtypes, form a heterogenous group of meningiomas with varying aggressiveness and clinical behavior. Objective: To demonstrate the differences of...
10.
Ren L, Cheng H, Chen J, Deng J, Wang D, Xie Q, et al.
J Neurosurg
. 2022 Nov;
139(1):49-58.
PMID: 36334291
Objective: Benefits of adjuvant radiotherapy (ART) after gross-total resection (GTR) of de novo atypical meningiomas (AMs) are controversial, and factors predictive of radiotherapy benefits in patients with de novo AMs...